Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
PepsiCo
PEP
|
+$192M |
| 2 |
Johnson & Johnson
JNJ
|
+$179M |
| 3 |
EMC
EMC CORPORATION
EMC
|
+$177M |
| 4 |
Chubb
CB
|
+$153M |
| 5 |
Eli Lilly
LLY
|
+$142M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$470M |
| 2 |
PRE
PARTNERRE LTD
PRE
|
+$186M |
| 3 |
Comcast
CMCSA
|
+$179M |
| 4 |
Pfizer
PFE
|
+$168M |
| 5 |
Gilead Sciences
GILD
|
+$144M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 12.85% |
| 2 | Technology | 12.31% |
| 3 | Financials | 12.27% |
| 4 | Industrials | 10.64% |
| 5 | Consumer Staples | 10.39% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2801
Chemung Financial Corp
CHMG
$403M
| $580K | ﹤0.01% |
22,000
+11,200
| +104% | +$305K |
|
2802
Kewaunee Scientific
KEQU
$104M
| $578K | ﹤0.01% |
34,700
+2,200
| +7% | +$36.9K |
|
|
BLD
2803
DELISTED
TopBuild
BLD
| $575K | ﹤0.01% |
19,346
-86,254
| -82% | -$2.33M |
|
2804
First Northwest Bancorp
FNWB
$107M
| $573K | ﹤0.01% |
44,500
+20,300
| +84% | +$259K |
|
2805
Orion Energy Systems
OESX
$84.2M
| $573K | ﹤0.01% |
41,240
+6,280
| +18% | +$103K |
|
|
BORN
2806
DELISTED
China New Borun Corporation
BORN
| $573K | ﹤0.01% |
409,547
+68,447
| +20% | +$109K |
|
|
BVSN
2807
DELISTED
Broadvision Inc Com
BVSN
| $573K | ﹤0.01% |
74,701
+9,201
| +14% | +$56.6K |
|
|
SXCP
2808
DELISTED
SunCoke Energy Partners, L.P.
SXCP
| $572K | ﹤0.01% |
+77,400
| New | +$545K |
|
|
AMOV
2809
DELISTED
America Movil SAB de CV
AMOV
| $570K | ﹤0.01% |
38,938
+18,056
| +86% | +$234K |
|
2810
Denison Mines
DNN
$2.95B
| $569K | ﹤0.01% |
1,011,500
+844,000
| +504% | +$392K |
|
|
PFBI
2811
DELISTED
Premier Financial Bancorp
PFBI
| $568K | ﹤0.01% |
49,595
+11,391
| +30% | +$128K |
|
|
PGLC
2812
DELISTED
Pershing Gold Corporation. Common Stock
PGLC
| $565K | ﹤0.01% |
+143,110
| New | +$540K |
|
|
RPT
2813
Rithm Property Trust
RPT
$99.9M
| $563K | ﹤0.01% |
+8,683
| New | +$545K |
|
2814
Madrigal Pharmaceuticals
MDGL
$12.4B
| $560K | ﹤0.01% |
66,657
-4,892
| -7% | -$40.9K |
|
2815
Energous
WATT
$82M
| $559K | ﹤0.01% |
+92
| New | +$379K |
|
2816
VanEck Semiconductor ETF
SMH
$72.5B
| $556K | ﹤0.01% |
+20,200
| New | +$510K |
|
|
IRD
2817
Opus Genetics
IRD
$313M
| $556K | ﹤0.01% |
3,512
+874
| +33% | +$145K |
|
|
TVRD
2818
Tvardi Therapeutics
TVRD
$22.1M
| $556K | ﹤0.01% |
2,483
+1,162
| +88% | +$347K |
|
|
HAYN
2819
DELISTED
Haynes International, Inc.
HAYN
| $555K | ﹤0.01% |
15,200
+500
| +3% | +$16.4K |
|
|
FSB
2820
DELISTED
Franklin Financial Network, Inc.
FSB
| $554K | ﹤0.01% |
20,500
-46,657
| -69% | -$1.27M |
|
2821
National Health Investors
NHI
$3.47B
| $552K | ﹤0.01% |
8,300
-40,200
| -83% | -$2.48M |
|
2822
Primoris Services
PRIM
$4.39B
| $552K | ﹤0.01% |
+22,700
| New | +$484K |
|
2823
Achieve Life Sciences
ACHV
$744M
| $551K | ﹤0.01% |
367
+23
| +7% | +$37.5K |
|
2824
Westlake Chemical Partners
WLKP
$778M
| $550K | ﹤0.01% |
+27,900
| New | +$518K |
|
|
BRSL
2825
Brightstar Lottery PLC
BRSL
$2.15B
| $548K | ﹤0.01% |
30,000
-59,028
| -66% | -$898K |
|
Similar funds
Jim Simons's Q1 2016 Portfolio in Review
As of Q1 2016, Jim Simons held 3,753 positions worth $52.6B, up 15% from $45.9B the previous quarter. Its ten largest holdings account for 7.9% of the portfolio.
Jim Simons deployed $5.31B of net new capital in Q1 2016, opening 498 new positions and adding to 2,018 existing holdings. Its largest new stake was EMC CORPORATION: 7,000,400 shares worth $187M.
By sector, the portfolio is most concentrated in Healthcare at 13% of assets, down from 14% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was Pfizer, an estimated $168M trimmed.
- Jim Simons's largest Q1 2016 buy was EMC CORPORATION: 7,000,400 shares worth $187M.
- Jim Simons added most to PepsiCo in Q1 2016, an estimated $192M increase.
- Jim Simons's biggest Q1 2016 reduction was Pfizer, cutting an estimated $168M.
- Jim Simons fully exited Apple in Q1 2016, selling an estimated $470M.
- Jim Simons's ten largest holdings make up 7.9% of its $52.6B portfolio in Q1 2016.
- Jim Simons opened 498 new positions and closed 403 in Q1 2016.
- Jim Simons's portfolio value rose 15% quarter-over-quarter to $52.6B.
Based on Renaissance Technologies's 13F filing for Q1 2016, filed 13 May 2016.